2m 2m 2m 2m 2m 2m 2m
Supernus Pharm (SUPN)
NASDAQ
$47.09-$0.26 (-0.55%)
Price as of Jul 14, 2026 5:57 AM EDT- $2.7BMarket Cap
- 39.43%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Supernus Pharm (SUPN)
$47.09-$0.26 (-0.55%)
SUPN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $47.35 | ||
Change | -$1.11 (-2.29%) | ||
Open | $48.09 | ||
High | $48.24 | ||
Low | $46.91 | ||
Previous Close | $48.46 | ||
Volume | 685,279 | ||
30-Day Average Volume | 1,029,821 | ||
1-Week Change | 0.23% | ||
1-Month Change | 6.62% | ||
1-Year Change | 39.43% | ||
3-Year Change | 56.32% | ||
5-Year Change | 70.08% | ||
Fundamentals | |||
Shares Outstanding | 58.0M | ||
Total Assets | $1.5B | ||
Market Cap | $2.7B | ||
Enterprise Value | $2.6B | ||
Period: QTR TTM FY | |||
Revenue | $150.8M | ||
Net Income | -$2.3M | ||
Free Cash Flow | $66.5M | ||
EBIT | -$6.0M | ||
EBITDA | $20.2M | ||
Net Working Capital | $357.7M | ||
EPS | -$0.04 | ||
Enterprise Value/EBITDA | 127 | ||
Enterprise Value/Revenue | 17 | ||
P/B | 3 | ||
P/E | -1,184 | ||
PEG | -26 | ||
Price/Free Cash Flow | 41 | ||
Price/Operating Cash Flow | 41 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue